CIK 0001841387
- Emerging growth company
Candel Therapeutics, Inc.
Sign in to watch- Ticker
- CADL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522214851
- Phone
- +1 617-916-5445
- Business address
- 117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,160,783
- in 1 filing, $3.2M under 10b5-1 plans
Net −$3,160,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-08 | Schoch Charles | Sale | −9,971 | $8.22 | $82K | 52,549 |
| 2025-01-08 | Tak Paul Peter Chief Executive Officer | Sale | −21,172 | $8.22 | $174K | 273,616 |
| 2025-01-08 | Tyagarajan Seshu Chief Technology Officer | Sale | −14,545 | $8.22 | $120K | 111,112 |
| 2025-01-08 | Nichols William Garrett Chief Medical Officer | Sale | −10,799 | $8.22 | $89K | 89,748 |
| 2024-11-29 | Tyagarajan Seshu Chief Technology Officer | Sale | −20,392 | $4.56 | $93K | 125,657 |
| 2024-11-29 | Tak Paul Peter Chief Executive Officer | Sale | −48,847 | $4.56 | $223K | 294,788 |
| 2024-11-29 | Nichols William Garrett Chief Medical Officer | Sale | −13,935 | $4.56 | $63K | 100,547 |
| 2024-11-29 | Barone Francesca Chief Scientific Officer | Sale | −22,081 | $4.56 | $101K | 137,880 |
| 2024-10-15 | Aguilar-Cordova Estuardo 10% owner | Sale | −10,412 | $6.03 | $63K | 919,461 |
| 2024-10-14 | Aguilar-Cordova Estuardo 10% owner | Sale | −15,000 | $6.02 | $90K | 929,873 |
| 2024-10-11 | Aguilar-Cordova Estuardo 10% owner | Sale | −15,000 | $6.05 | $91K | 944,873 |
| 2024-10-03 | Aguilar-Cordova Estuardo 10% owner | Sale | −1,800 | $6.85 | $12K | 959,873 |
| 2024-10-02 | Aguilar-Cordova Estuardo 10% owner | Sale | −26,988 | $6.92 | $187K | 961,673 |
| 2024-10-01 | Aguilar-Cordova Estuardo 10% owner | Sale | +6,214 | $7.01 | $44K | 988,661 |
| 2024-07-17 | Tyagarajan Seshu Chief Technology Officer | Sale | −14,851 | $6.47 | $96K | 146,049 |
| 2024-07-17 | Tak Paul Peter Chief Executive Officer | Sale | −22,528 | $6.47 | $146K | 330,735 |
| 2024-07-17 | Schoch Charles | Sale | −9,884 | $6.47 | $64K | 62,520 |
| 2024-07-17 | Nichols William Garrett Chief Medical Officer | Sale | −10,875 | $6.47 | $70K | 114,482 |
| 2024-07-17 | Barone Francesca Chief Scientific Officer | Sale | −14,051 | $6.47 | $91K | 159,961 |
| 2024-07-11 | Tyagarajan Seshu Chief Technology Officer | Sale | −13,330 | $5.97 | $80K | 160,900 |
Page 2 of 3 · 44 trades